Schizophrenia: effects of aripiprazole in metabolic syndrome. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 55, p. e17840, 2019. DOI: 10.1590/s2175-97902019000217840. Disponível em: https://revistas.usp.br/bjps/article/view/164787.. Acesso em: 5 may. 2024.